Dr. Michael Hull
Pulmonary Disease · Edmond, OK
CMS Profile ID: 289786 · NPI: 1396891743
F
Payment Grade
High payments ($100,000+). This grade reflects disclosed general payments in CMS Open Payments program year 2024 only.
Total Disclosed Payments
$638,158
Number of Payments
55
Transparency Score
1/5
Payments by Type
| Payment Type | Amount |
|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $637,275 |
| Food and Beverage | $862 |
| Education | $22 |
Top Paying Companies
| Manufacturer / GPO | Amount |
|---|---|
| CIPLA USA INC. | $637,275 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $289 |
| GlaxoSmithKline, LLC. | $141 |
| Baxter Healthcare | $118 |
| GENZYME CORPORATION | $59 |
| Vifor Pharma, Inc. | $56 |
Top contributing companies shown; smaller payers may be omitted.
These totals are computed from the official CMS Open Payments program-year 2024 general-payment
file. To see the full, authoritative record for this provider — including research payments and
line-item detail — look them up by name or NPI on the
official CMS Open Payments portal.
What should I ask my doctor?
- Are you a paid speaker or consultant for any pharmaceutical or device company?
- Do any of your prescribing choices reflect relationships with industry?
- Is there an equivalent generic or alternative treatment?